# Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

> **NCT06344338** · NA · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 32 (estimated)

## Conditions studied

- Refractory Status Epilepticus

## Interventions

- **DEVICE:** tDCS stimulation
- **DEVICE:** TDCS sham-stimulation

## Key facts

- **NCT ID:** NCT06344338
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344338, "Application of tDCS Stimulation in Controlling Refractory Status Epilepticus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06344338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*